Hangzhou Tigermed Consulting Co., Ltd. Announces Successful Poll Voting Results for Share Repurchase at Extraordinary General Meetings
Hangzhou Tigermed Consulting Co., Ltd. (Stock Code: 3347) has released detailed results from its 2026 Second Extraordinary General Meeting (EGM), Second A Share Class Meeting, and Second H Share Class Meeting, held on June 9, 2026. This announcement contains crucial information for shareholders and investors, with several resolutions that may be price-sensitive and have the potential to impact the company’s share value.
Key Points from the Report
- EGM and Class Meetings Successfully Convened: All proposed resolutions were passed by shareholders via poll voting.
- Share Repurchase Plan Approved: The central topic was the approval of repurchase of A Shares through centralized price bidding. This is a material event that could affect share supply and potentially impact the share price.
- High Shareholder Participation: Nearly half (49.92%) of eligible shares participated in the vote, with broad support shown for all resolutions.
- No Abstentions or Negative Votes of Significance: No shareholders were required to abstain, and no relevant parties indicated intentions to vote against or abstain from the resolutions.
- Legal Compliance: The meetings were confirmed as legal and valid by Jia Yuan Law Offices, ensuring the process meets regulatory standards.
- Detailed Voting Breakdown: All special resolutions concerning the share repurchase were passed with overwhelming majorities, notably:
- Purpose and Usage of Share Repurchase: 99.95% in favor.
- Conditions, Methods, Amount, Source of Funds, and Pricing: Each passed with more than 97% positive votes.
- Mandate for Management to Execute Repurchase: 99.95% in favor.
- Price/Range Principle: Resolution 1.6 (pricing principle) saw slightly lower approval (~97.4% overall; 95.9% for H shares), suggesting some shareholder concerns around the repurchase price, which could signal sensitivity to repurchase terms and future share value.
- Publication of Results: The company will publish voting results on HKEX and Shenzhen Stock Exchange websites for shareholder reference.
Shareholder Information – Potential Price Impact
- Share Repurchase as a Market Signal: Approval to repurchase A Shares can lead to reduced outstanding share count, potentially boosting earnings per share and improving return metrics. Historically, share repurchase programs are seen as positive for share price, as they may indicate management confidence in the company’s prospects.
- Strong Shareholder Support: The overwhelming approval from both A and H shareholders indicates strong confidence in the company’s direction and management policies, which could further support price stability or appreciation.
- No Opposition or Abstention: The absence of significant dissent or abstention suggests broad consensus, reducing the risk of shareholder disputes that could negatively impact share value.
- Repurchase Pricing Sensitivity: Slightly lower approval for the pricing principle suggests investors are closely watching the price at which shares are repurchased, which may affect future trading sentiment.
- Legal Validity: Confirmation of legal compliance reduces regulatory risk, supporting investor confidence.
Detailed Voting Results
| Resolution | A Shares For (%) | H Shares For (%) | Total For (%) | Against (%) | Abstain (%) |
|---|---|---|---|---|---|
| Purpose & Usage | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
| Conditions | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
| Methods | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
| Type & Number | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
| Amount & Source | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
| Price Principle | 97.61 | 95.90 | 97.40 | 2.60 | 0.002 |
| Repurchase Period | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
| Management Mandate | 99.94 | 100 | 99.95 | 0.05 | 0.002 |
Conclusion
The approval of the A Share repurchase plan is a significant event for Hangzhou Tigermed Consulting Co., Ltd. and its investors. The strong support from shareholders, especially regarding the repurchase plan, is likely to be viewed positively in the market. The only minor concern is around the pricing principle, but overall, the resolutions passed with overwhelming majorities. This could potentially lead to upward movement in the share price, subject to market reactions and execution of the repurchase program.
Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell securities. Investors should conduct their own due diligence and seek professional advice before making any investment decisions.
